Victus has been sold to Megalabs


Headquartered in Miami, Victus, Inc. is a global leader in clinical nutrition, needle-free connectology, infusion, critical care systems and advanced wound care. All the company’s products are developed and refined using medical professional and patient feedback, and its Enterex brand of nutritional supplements has become one of the most trusted and recognizable names in the industry. Victus generates sales in more than 25 countries and more than 28,000 retail locations across all of North, Central and South America.

The Deal

In 2020, the company launched multiple strategic, management-led initiatives that delivered meaningful, permanent margin improvement. In 2021, Victus saw significant geographic expansion in both new and existing territories, driving strong revenue growth. Given the company’s new financial profile, management began considering options to best support the company’s strong growth trajectory. In late-2021, the shareholders engaged Lincoln International to execute a bespoke sale process to identify a new partner to support the company’s next phase.

Our Perspective

Roddy O’Neill, Managing Director and Co-Head of Lincoln’s U.S. Healthcare Group, commented, “We are grateful to have had the opportunity to work with such an innovative company like Victus. Management has built a tremendous platform, and we look forward to tracking the company’s continued growth with its new partner, Megalabs.”

Victus MegaLabs 2022 Connect with a Senior Team Member

Meet our Senior Team

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.